Crosscheck

Your medical. Crosschecked.

Other

Enclomiphene citrate

Named in the FAA's low testosterone (hypogonadism) table and worksheet
Other names: enclomiphene

FAA guidance

FAA review required.

Examiner

FAA review required; the examiner defers

Source: FAA, Low Testosterone (Low T) Hypogonadism. FAA date 29 April 2026. Checked by Crosscheck 14 October 2026

The FAA's low testosterone (hypogonadism) worksheet says: "Enclomiphene citrate is NOT acceptable."

Track your medications
Compare FAA documents: enclomiphene citrateWhat each of the two FAA documents says, in plain wordsOpen

Its table prints the same note in row C, all others, where the information is submitted for FAA review and the examiner defers, for a possible special issuance.

Show the FAA's words: enclomiphene citrateThe official FAA wording: two passages, each with its document and dateOpen
FAA, Low Testosterone (Low T) Hypogonadism · FAA date 29 April 2026
C. All others
Note: Use of enclomiphene citrate is NOT acceptable.
Submit the following for FAA review:
DEFER
Submit the information to the FAA for a possible Special Issuance
FAA, CACI – Low Testosterone (Low T) Hypogonadism Worksheet · FAA date 29 April 2026
Medications for condition (one or more of the following):
Note: Enclomiphene citrate is NOT acceptable.
Sources and dates: enclomiphene citrateTwo FAA documents, with the FAA's date and when Crosscheck checked themOpen

See also

Medication guidance alone does not determine whether a pilot is medically qualified to fly. The underlying condition, dosage, side effects, medication combinations, and certification history may affect FAA eligibility.

For informational purposes only. Not legal or medical advice.